UNASSIGNED: Adverse neurological side effects associated with @entity1313 and their treatments contribute to long-term neurocognitive morbidity. Measures designed to quantify @entity5 -related risk factors are lacking. The @entity16 ( @entity16 ) is designed to assess treatment-related neurological risks. Preliminary validation established associations between the @entity16 and global cognitive functioning in this population, though its associations with specific neurobehavioral domains has yet to be addressed. @entity1 referred for outpatient neuropsychological assessment completed performance-based measures of intellectual, attentional, working memory, motor speed, and executive abilities. Caregivers completed ratings of adaptive functioning. Neuropsychological and adaptive data were available for 100 @entity1313 survivors (51  % female), ages 6 to 22  years (M  =  12.83, SD  =  4.37). Total @entity16 scores were generated via retrospective medical record review. Total @entity16 scores were significantly associated with several neurocognitive composite scores including verbal reasoning and working memory, after controlling for years post-diagnosis (ps  <  .05). @entity16 scores also were significantly associated with performance-based measures of attention, executive functioning, and cognitive efficiency (ps  <  .05). No significant relationship was demonstrated between @entity16 scores and caregiver-reported adaptive behavior skills (ps  >  .05). Results indicate that the @entity16 is associated with performance-based neurocognitive functioning and executive skills but not with functioning in specific caregiver-reported adaptive behavior domains. The @entity16 offers some value as a resource for understanding associations between treatment-related neurological risks and select aspects of neurocognitive morbidity. Future studies should examine whether the @entity16 can aid in planning appropriate therapeutic intervention as survivors progress into early adulthood.

Associations among treatment-related neurological risk factors and neuropsychological functioning in survivors of childhood XXXX .

@entity5 :: ('MESH:D009369', 'Disease') :: ['tumor'] @entity1 :: ('9606', 'Species') :: ['Participants'] @entity16 :: ('MESH:D009422', 'Disease') :: ['neurological predictor scale', 'NPS'] @entity1313 :: ('MESH:D001932', 'Disease') :: ['childhood brain tumors', 'brain tumor']
@entity1313 :: (MESH:D001932,Disease) :: ['brain tumor']
